Related Experiment Video
Updated: Aug 18, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
Amphotericin B. Still the 'gold standard' for antifungal therapy
1Department of Internal Medicine, Maricopa Medical Center, Phoenix, AZ 85008.
Abstract:
Amphotericin B (Fungizone) remains the cornerstone of antifungal therapy because of its broad-spectrum fungicidal activity and rapid onset of action. Ketoconazole (Nizoral) and the new triazoles are welcome additions to the therapeutic armamentarium but do not replace amphotericin B. Adverse side effects of amphotericin B treatment are usually manageable and often preventable. Careful attention to detail reduces immediate toxicity and allows completion of the desired therapeutic course without an undue risk of permanent nephrotoxicity.
Related Concept Videos
Fungal Phylum Ascomycota
Cryptococcal Meningitis
Candidiasis
Antifungal Agents
Anthelminthic Agents
Antiprotozoal Agents

